Dr. MeiLan Han elected to the COPD Foundation Board of Directors
Miami, FL– April 19, 2021 The COPD Foundation, a not-for-profit organization focused on improving the lives of those affected by and stopping the progression of COPD and related lung conditions, has announced the election of Dr. MeiLan Han to its Board of Directors.
"We are delighted to welcome MeiLan to our Board," noted COPD Foundation Board Chair Dr. James D. Crapo. "MeiLan is a longtime researcher and advocate for lung health, and joins a team of supporters that includes noted practitioners who lend their expertise to our mission. We are so appreciative that she will join our team of community leaders committed to improving the lives of patients and caregivers."
MeiLan Han, MD MS, is a Professor of Medicine in the Division of Pulmonary and Critical Care at the University of Michigan. Dr. Han received her medical degree from the University of Washington in Seattle, WA. She completed her residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Han has also completed a Master's Degree program in Biostatistics and Clinical Study Design at the University of Michigan School of Public Health.
Dr. Han is co-chair of the University of Michigan COPD Quality Improvement Committee and co-authored the University of Michigan COPD Guidelines. Dr. Han’s research has focused on defining phenotypes in COPD using lung imaging. She is a lead investigator for several NIH sponsored COPD studies and a member of the COPD Foundation’s COPD360Net Steering Committee. She also serves on the Medical and Scientific Advisory Committees for both the COPD Foundation and the American Lung Association and serves as a spokesperson for the American Lung Association. She is currently an Associate Editor for the American Journal of Respiratory and Critical Care Medicine and serves on the editorial boards for Thorax, Lancet Respiratory Medicine and the Journal of the COPD Foundation. She is also a member of the Global Obstructive Lung Disease (GOLD) scientific committee which is charged with developing internationally recognized consensus statement on COPD diagnosis and management.